Ultragenyx Pharmaceutical Inc. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2017 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Sell | S | 86.34 | 2,500 | 215,845 | 9,709 | 12.2 K to 9.7 K (-20.48 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | A | 88.80 | 28,000 | 2,486,400 | 28,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Grant | A | 0.00 | 4,000 | 0 | 55,887 | 51.9 K to 55.9 K (+7.71 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Option Exercise | A | 88.80 | 18,000 | 1,598,400 | 18,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Grant | A | 0.00 | 2,700 | 0 | 12,495 | 9.8 K to 12.5 K (+27.57 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 88.80 | 12,000 | 1,065,600 | 12,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 2,000 | 0 | 9,500 | 7.5 K to 9.5 K (+26.67 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Option Exercise | A | 88.80 | 25,000 | 2,220,000 | 25,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Grant | A | 0.00 | 3,000 | 0 | 76,790 | 73.8 K to 76.8 K (+4.07 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | A | 88.80 | 78,000 | 6,926,400 | 78,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 13,000 | 0 | 432,647 | 419.6 K to 432.6 K (+3.10 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 88.80 | 15,000 | 1,332,000 | 15,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 2,000 | 0 | 11,795 | 9.8 K to 11.8 K (+20.42 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Option Exercise | A | 88.80 | 30,000 | 2,664,000 | 30,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 4,500 | 0 | 16,960 | 12.5 K to 17 K (+36.12 %) |